批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2016/04/18 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2008/08/08 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/12/09 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/05/19 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/11/14 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/11/14 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/07/12 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/03/15 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/02/25 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/05/29 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/01/08 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/10/29 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/04/12 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1994/04/14 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1993/11/09 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1993/04/22 |
SUPPL-4(补充) |
Approval |
Labeling |
|
|
|
1992/02/26 |
SUPPL-3(补充) |
Approval |
Efficacy |
|
|
|
1991/04/30 |
SUPPL-2(补充) |
Approval |
Labeling |
|
|
|
1990/04/26 |
SUPPL-1(补充) |
Approval |
Labeling |
|
|
|
1989/12/22 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:ACYCLOVIR 剂型/给药途径:SUSPENSION;ORAL 规格:200MG/5ML 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019909 |
001 |
NDA |
ZOVIRAX |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Discontinued |
Yes |
No |
AB |
1989/12/22
|
NORVIUM BIOSCIENCE |
074738 |
001 |
ANDA |
ACYCLOVIR |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Prescription |
No |
No |
AB |
1997/04/28
|
ACTAVIS MID ATLANTIC |
077026 |
001 |
ANDA |
ACYCLOVIR |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Discontinued |
No |
No |
AB |
2005/06/07
|
HIKMA |
212718 |
001 |
ANDA |
ACYCLOVIR |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Prescription |
No |
No |
AB |
2020/04/23
|
CHARTWELL RX |
212252 |
001 |
ANDA |
ACYCLOVIR |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Prescription |
No |
Yes |
AB |
2020/07/10
|
NOVITIUM PHARMA |
216331 |
001 |
ANDA |
ACYCLOVIR |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Prescription |
No |
No |
AB |
2022/03/31
|
AUROBINDO PHARMA |
215669 |
001 |
ANDA |
ACYCLOVIR |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Prescription |
No |
No |
AB |
2022/07/01
|
HETERO LABS LTD III |
215724 |
001 |
ANDA |
ACYCLOVIR |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Prescription |
No |
No |
AB |
2022/08/18
|
RUBICON |
217393 |
001 |
ANDA |
ACYCLOVIR |
ACYCLOVIR |
SUSPENSION;ORAL |
200MG/5ML |
Prescription |
No |
No |
AB |
2023/03/09
|
MSN |